The session successfully shed light on the journey that medical products—including drugs, vaccines, diagnostic tests, medical devices, and biological therapeutics—undergo before reaching patients. These products, collectively termed as ‘Medical Products’, are subjected to rigorous testing processes required for regulatory approval. While the specific protocols vary based on the type of product, the journey almost always begins with a proof of principle derived from foundational and translational research.